West Ward

West-Ward Pharmaceuticals was a leading American manufacturer of generic prescription medicines and served as the primary U.S. subsidiary of Hikma Pharmaceuticals. Founded in 1946, the company specialized in developing and marketing a diverse range of generic products, including oral solids, liquid unit doses, and injectable medications. In 2016, West-Ward significantly expanded its operations and portfolio through the acquisition of Roxane Laboratories from Boehringer Ingelheim, which added a major manufacturing site in Columbus, Ohio. The company was known for its focus on high-quality, affordable healthcare solutions across therapeutic areas such as oncology and respiratory health. In 2018, Hikma consolidated its global identity and rebranded West-Ward Pharmaceuticals under the Hikma name to unify its corporate image.